|
Volumn 67, Issue 6, 2000, Pages 672-678
|
Delivery of fenoterol via Respimat®, a novel 'soft mist' inhaler: A randomised, double-blind (within device), placebo-controlled, cross-over, dose-ranging study in asthmatic patients
a a b b c d |
Author keywords
Asthma; Fenoterol; Respimat
|
Indexed keywords
CHLOROFLUOROCARBON;
FENOTEROL;
PLACEBO;
ADULT;
AGED;
ARTICLE;
ASTHMA;
BRONCHODILATATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HEADACHE;
HUMAN;
INHALER;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MALE;
METERED DOSE INHALER;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AEROSOL PROPELLANTS;
AGED;
ASTHMA;
BRONCHODILATOR AGENTS;
CHLOROFLUOROCARBONS, METHANE;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
EQUIPMENT DESIGN;
FEMALE;
FENOTEROL;
FORCED EXPIRATORY VOLUME;
HUMANS;
MALE;
MIDDLE AGED;
NEBULIZERS AND VAPORIZERS;
TIME FACTORS;
TREATMENT OUTCOME;
VITAL CAPACITY;
|
EID: 0034532251
PISSN: 00257931
EISSN: None
Source Type: Journal
DOI: 10.1159/000056298 Document Type: Article |
Times cited : (19)
|
References (13)
|